Dimethylformamide → HCID 178522790、化合物
反応式
C[Si](C)(C)CCOC[N:7]1[C:11]2=[N:12][CH:13]=[CH:14][CH:15]=[C:10]2[C:9]([C:16]2[S:20][C:19]([CH2:21][NH2:22])=[CH:18][CH:17]=2)=[N:8]1.[F:25][C:26]1[CH:27]=[C:28]([CH:40]=[CH:41][C:42]=1[F:43])[CH2:29][N:30]1[CH:35]=[CH:34][CH:33]=[C:32]([C:36](O)=[O:37])[C:31]1=[O:39].CN(C(ON1N=NC2C=CC=NC1=2)=[N+](C)C)C.F[P-](F)(F)(F)(F)F.CN(C)C=O.C(N(CC)C(C)C)(C)C>C(O)(=O)CC(CC(O)=O)(C(O)=O)O.O>[NH:7]1[C:11]2=[N:12][CH:13]=[CH:14][CH:15]=[C:10]2[C:9]([C:16]2[S:20][C:19]([CH2:21][NH:22][C:36]([C:32]3[C:31](=[O:39])[N:30]([CH2:29][C:28]4[CH:40]=[CH:41][C:42]([F:43])=[C:26]([F:25])[CH:27]=4)[CH:35]=[CH:34][CH:33]=3)=[O:37])=[CH:18][CH:17]=2)=[N:8]1参加物
反応物 5
生成物 1
試薬・触媒・溶媒 2
実験手順
C-{5-[1-(2-Trimethylsilanyl-ethoxymethyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]-thiophen-2-yl}-methylamine (23 mg, 0.000064 mol), 1-(3,4-difluoro-benzyl)-2-oxo-1,2-dihydro-pyridine-3-carboxylic acid (2.0E1 mg, 0.000075 mol) and HATU (44 mg, 0.00012 mol; Applied Biosystems) were dissolved in N,N-dimethylformamide (1.25 mL, 0.0161 mol; Acros). To this was added N,N-diisopropylethylamine (56 uL, 0.00032 mol; Aldrich) and the reaction was stirred for 1 hour at room temperature. The reaction was diluted with 5% citric acid in water, then extracted with ethyl acetate. Saturated sodium chloride was added to aid separation. The organic layer was washed with saturated sodium chloride, dried with sodium sulfate, filtered and evaporated to yield the crude title compound. MS m/z=608.34 (M+1).
後処理
- extractionextracted with ethyl acetate
- additionSaturated sodium chloride was added
- customseparation
- washThe organic layer was washed with saturated sodium chloride
- dry with materialdried with sodium sulfate
- filtrationfiltered
- customevaporated
出典と根拠
- ORDレコード
- ord-9c8ecf8a04804a4db8f630c4134e98b2
- 出典データセット
- uspto-grants-2014_07
- 特許番号
- US08778977B2
反応ノート
読み込み中…